MX428671B - COMPOSICIONES DE PIRROLO[2,3-b]PIRIDINA-3-CARBOXAMIDA Y MÉTODOS PARA MEJORAR LA PÉRDIDA DE AUDICIÓN - Google Patents

COMPOSICIONES DE PIRROLO[2,3-b]PIRIDINA-3-CARBOXAMIDA Y MÉTODOS PARA MEJORAR LA PÉRDIDA DE AUDICIÓN

Info

Publication number
MX428671B
MX428671B MX2022009572A MX2022009572A MX428671B MX 428671 B MX428671 B MX 428671B MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 428671 B MX428671 B MX 428671B
Authority
MX
Mexico
Prior art keywords
pyrrolo
pyridine
hearing loss
methods
improving hearing
Prior art date
Application number
MX2022009572A
Other languages
English (en)
Other versions
MX2022009572A (es
Inventor
A James Hudspeth
David John Huggins
John David Ginn
Ksenia Gnedeva
Leigh Ashley Baxt
Nathaniel Kastan
Nigel John Liverton
Peter T Meinke
Robert Walter Myers
Rui Liang
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of MX2022009572A publication Critical patent/MX2022009572A/es
Publication of MX428671B publication Critical patent/MX428671B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe N-(tiazol-2(3H)-iliden 3-sustituido)-1H-pirrolo[2,3-b]piridin-3-carboxamidas y N-(oxazol-2(3H)- iliden 3-sustituido)-1H- pirrolo[2,3-b]piridin-3-carboxamidas (ver Fórmulas) Los compuestos activan Yap e inhiben las cinasas Lats. Por lo tanto, son útiles para tratar la pérdida de audición.
MX2022009572A 2020-02-05 2021-02-05 COMPOSICIONES DE PIRROLO[2,3-b]PIRIDINA-3-CARBOXAMIDA Y MÉTODOS PARA MEJORAR LA PÉRDIDA DE AUDICIÓN MX428671B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062970425P 2020-02-05 2020-02-05
PCT/US2021/016848 WO2021158936A1 (en) 2020-02-05 2021-02-05 Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss

Publications (2)

Publication Number Publication Date
MX2022009572A MX2022009572A (es) 2022-12-13
MX428671B true MX428671B (es) 2025-11-13

Family

ID=77199407

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009572A MX428671B (es) 2020-02-05 2021-02-05 COMPOSICIONES DE PIRROLO[2,3-b]PIRIDINA-3-CARBOXAMIDA Y MÉTODOS PARA MEJORAR LA PÉRDIDA DE AUDICIÓN

Country Status (9)

Country Link
US (1) US12617785B2 (es)
EP (1) EP4100008B1 (es)
JP (1) JP7678595B2 (es)
CN (1) CN115515579B (es)
AU (1) AU2021215925B2 (es)
CA (1) CA3170121A1 (es)
ES (1) ES3025983T3 (es)
MX (1) MX428671B (es)
WO (1) WO2021158936A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115515579B (zh) 2020-02-05 2025-09-30 洛克菲勒大学 吡咯并[2,3-b]吡啶-3-甲酰胺组合物和改善听力损失的方法
EP4380562A4 (en) * 2021-08-02 2025-05-21 The Rockefeller University PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELL PROLIFERATION
EP4687896A1 (en) * 2023-04-04 2026-02-11 Children's Hospital Los Angeles Lats kinase inhibitor to treat retinal degeneration
WO2026010871A1 (en) * 2024-07-01 2026-01-08 Hudspeth A James ((pyrrolopyridine-3-carbonyl) imino)-2,3-dihydrothiazol-4-yl) methyl phosphates for activating yap
KR20260029093A (ko) * 2024-08-23 2026-03-04 한국화학연구원 카이네이즈 억제제
WO2026043170A1 (ko) * 2024-08-23 2026-02-26 한국화학연구원 카이네이즈 억제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
WO2007067537A1 (en) * 2005-12-07 2007-06-14 Osi Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
PE20121126A1 (es) * 2006-12-21 2012-08-24 Plexxikon Inc Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
KR101591153B1 (ko) 2010-12-20 2016-02-02 그렌마크 파머수티칼스 에스. 아. Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물
TWI667233B (zh) * 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
GB201602854D0 (en) * 2016-02-18 2016-04-06 Mission Therapeutics Ltd Novel compounds
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
CN115515579B (zh) 2020-02-05 2025-09-30 洛克菲勒大学 吡咯并[2,3-b]吡啶-3-甲酰胺组合物和改善听力损失的方法

Also Published As

Publication number Publication date
CA3170121A1 (en) 2021-08-12
AU2021215925B2 (en) 2026-04-09
JP2023512823A (ja) 2023-03-29
CN115515579B (zh) 2025-09-30
EP4100008A1 (en) 2022-12-14
CN115515579A (zh) 2022-12-23
US20230137893A1 (en) 2023-05-04
MX2022009572A (es) 2022-12-13
WO2021158936A1 (en) 2021-08-12
EP4100008A4 (en) 2024-02-07
ES3025983T3 (en) 2025-06-10
AU2021215925A1 (en) 2022-09-08
JP7678595B2 (ja) 2025-05-16
EP4100008B1 (en) 2025-04-02
US12617785B2 (en) 2026-05-05